1. Scope and Purpose of the Project
===================================

The main object of the present project was to record the infrared absorption spectra of the *N*-acetyl derivatives of a variety of glycopyranosylamines and their acetate esters, so that assignments of group frequencies could be made.

The spectra of five *N*-glycopyranosylacetamides and of six acetate esters thereof have been recorded, and the spectra of five related compounds have been examined. For comparison, the spectra of eight reducing, pyranose acetates are also presented.

2. Compounds Investigated
=========================

[Table 1](#t1-jresv65an1p31_a1b){ref-type="table"} gives a list of the compounds, their code numbers \[[@b1-jresv65an1p31_a1b]\],[1](#fn1-jresv65an1p31_a1b){ref-type="fn"} and an index to the spectrograms; the serial number of a compound is the same as the number of its spectrogram.

The spectra were measured in the region of 5000 to 667 cm^−1^ (sodium chloride optics) and in the region of 667 to 250 cm^−1^ (cesium bromide optics). The spectrograms are given together with a discussion of (a) the structure of the compounds and (b) some of the outstanding features of their spectra.

The first 16 compounds listed in [table 1](#t1-jresv65an1p31_a1b){ref-type="table"} all have an *acetamido* group attached to carbon atom 1. Fourteen of them have the pyranoid ring, but two of these amides (compounds 15 and 16) are open-chain derivatives of an alditol and, presumably, have a modified form of the planar, zigzag conformation. Eight of these compounds have hydroxyl groups, and eight are acetate esters; two of the amides (compounds 3 and 13) are hydrates. Compounds 17 to 24 have a *hydroxyl* group attached to the anomeric carbon atom, and all of them are acetate esters of pyranoid sugars.

The seven pyranoid 1-acetamido compounds having free hydroxyl groups differ in regard to one or more of the following structural features: (a) The *α* or *β* anomeric configuration at carbon atom 1; (b) the configurations of the other carbon atoms of the pyranoid ring (including C5 in the hexopyranosyl derivatives and hexuronamides); and (c) the nature of the substituent, if any, at C5. Similar distinctions apply to their acetate esters and to the reducing, acetylated pyranoses.

3. Classification of the 1-Acetamido Derivatives Into Structurally and Configurationally Related Groups
=======================================================================================================

The 16 compounds (1 to 16) were divided into two structural groups, according to whether they did or did not have a pyranoid ring.

The pyranoid compounds were divided into three groups; the members of each group have like configurational features.

3.1. *N*-Glycopyranosylacetamides of the *xylo* Configuration
-------------------------------------------------------------

The members of this group have the following general formula (I).
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Compounds 1, 2, 6, and 7 have the above general formula, with the following substituents. 1.*N*-Acetyl-*β*-[d]{.smallcaps}-xylopyranosylamine, R=H; R′ = H.2.*N*-Acetyl-*β*-[d]{.smallcaps}-glucopyranosylamine, R=H; R′ = CH~2~OH.6.*N*-Acetyl-2,3,4-tri-*O*-acetyl-*β*-[d]{.smallcaps}-xylosylamine, R = Ac; R′=H.7.*N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucosylamine, R=Ac; R′ = CH~2~OAc.

3.2. *N*-Glycopyranosylacetamides of the *lyxo* Configuration
-------------------------------------------------------------

The members of this group have the following general formula (II).

Compounds 3, 12, 8, and 14 have this general formula, with the following substituents. 3.*N*-Acetyl-*β*-[d]{.smallcaps}-mannopyranosylamine, monohydrate, R=H; R′=CH~2~OH.12.1-Acetamido-1-deoxy-?-[d]{.smallcaps}-mannopyranuronamide, R=H; R′ = CONH~2~, and the disposition at C1 *may* be the opposite of that depicted.8.*N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-mannosylamine, R=Ac; R′=CE~2~OAc.14.1-Acetamido-2,3,4-tri-*O*-acetyl-1-deox**y-?**-[d]{.smallcaps}-mannuronamide, R=Ac; R′=CONE~2~, and the disposition at C1 *may* be the opposite of that depicted.
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3.3. *N*-Glycopyranosylacetamides of the *arabino* Configuration
----------------------------------------------------------------

The members of this group have the following general formula (III).
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Compounds 10 and, possibly, 13 have the above general formula, with the following substituents. 10.*N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-galactosylamine, R=Ac; R′ = CH~2~OAc.13.1-Acetamido-1-deox-*α*(?)-[d]{.smallcaps}-galactopyranuronamide pentallydrate, R=H; R′ = CONH~2~.

Compounds 4, 5, 9, and 11 (and, possibly, 13) have formula IV, with the substituents indicated.
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1.  *N*-Acetyl-*α*-[l]{.smallcaps}-arabinopyranosylamine, R=H; R′=H.

2.  *N*-Acetyl-*β*-[d]{.smallcaps}-galactopyranosylamine, R=H; R′ = CH~2~OH.

3.  *N*-Acetyl-2,3,4-tri-*O*-acetyl-*α*-[l]{.smallcaps}-arabinosylamine, R=Ac; R′ = H.

4.  *N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactosylamine, R=Ac; R′ = CH~2~OAc.

5.  1-Acetamido-1-deoxy-*β*(?)-[d]{.smallcaps}-galactopyranuronamide pentahydrate, R=H; R′ = CONH~2~.

3.4. 1,1-Bis(acetamido)-1-deoxypentitol Derivatives
---------------------------------------------------

Compounds 15 and 16 have the general formula V, with the following substituents.
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1.  1,1-Bis(acetamido)-1-deoxy-[l]{.smallcaps}-arabinitol, R = H.

2.  1,1-Bis(acetamido)-2,3,4,5-tetra-*O*-acetyl-1-deoxy-[l]{.smallcaps}-arabinitol, R=Ac.

These compounds probably adopt a modified form of the planar, zigzag conformation depicted in general formula VI.
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4. Classification of the Reducing, Acetylated Pyranoses Into Structurally and Configurationally Related Groups
==============================================================================================================

These eight pyranoid acetates (compounds 17 to 24) were divided into four configurational groups. Three of the compounds (18, 20, and 22) are ketose derivatives.

4.1. Reducing, Acetylated Pyranoses of the *xylo* Configuration
---------------------------------------------------------------

The members of this group have the following general formula (VII).
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Compounds 17 to 20 have the above general formula, with the following substituents. 17.2,3,4-Tri-O-acetyl-*α*-[d]{.smallcaps}-xylopyranose, R=H; R′=OH; and R″=H.18.1,3,4,5-Tetra-*O*-acetyl-*α*-[l]{.smallcaps}-*xylo*-hexulopyranose (1,3,4,5-tetra-*O*-acetyl-*α*-[l]{.smallcaps}-sorbopyranose), R = CH~2~OAc; R′=OH; R″ = H; and the molecule is the mirror image of that depicted.19.2,3,4,6-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucopyranose, R = OH; R′=H; and R″=CH~2~OAc.20.1,3,4,5,7-Penta-*O*-acetyl-*α*-[d]{.smallcaps}-*gluco*-heptulopyranose, R = CH~2~OAc; R′=OH; and R″ = CH~2~OAc.

4.2. Reducing, Acetylated Pyranose of the *lyxo* Configuration
--------------------------------------------------------------

Compound 21 has the following formula (VIII).
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1.  2,3,4,6-Tetra-*O*-acetyl-*α*-[d]{.smallcaps}-mannopyranose

4.3. Reducing, Acetylated Pyranoses of the *arabino* Configuration
------------------------------------------------------------------

These compounds have the following general formula (IX).
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1.  1,3,4,5-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-*arabino*-hexulopyranose (1,3,4,5-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-fructopyranose), R=OH; R′ = CH~2~OAc; and R″=H.

2.  2,3,4,6-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactopyranose, R = H; R′=OH; R″ = CH~2~OAc; and the molecule is the mirror image of that depicted.

4.4. Reducing, Acetylated Pyranose of the *ribo* Configuration
--------------------------------------------------------------

Compound 24 has the following formula (X).
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1.  2,3,4,6-Tetra-*O*-acetyl-*α*-[d]{.smallcaps}-talopyranose

5. Discussion of the Spectra
============================

In the present study, the *positions* of the various absorption bands for each of 24 sugar derivatives have been determined; the relative intensities of absorption were not examined in detail. The bands were compiled, and were studied by statistical and comparative methods, as previously described \[[@b2-jresv65an1p31_a1b]\].

All of the compounds in the present study *and* all 19 of the (monosaccharide) acetylated methyl aldopyranosides previously examined \[[@b3-jresv65an1p31_a1b]\] show bands in the following spectral regions (alternative interpretations and some tentative assignments in parentheses): at 2994 to 2933 cm^−1^ (or 2976 to 2907 cm^−1^; C---H stretching); at 1449 to 1408 cm^−1^ (C---H bending); at 1379 to 1366 cm^−1^ (CH~3~---C deformation); at 1282 to 1247 cm^−1^ (acetyl, attached to nitrogen or to oxygen); at 1151 to 1114 cm^−1^; at 1107 to 1074 cm^−1^ (C---O stretching); at 1072 to 1052 cm^−1^; at 1050 to 1016 cm^−1^; at 962 to 933 cm^−1^; at 917 to 895 cm^−1^ (or 903 to 862 cm^−1^); at 636 to 600 cm^−1^ (or 625 to 597 cm^−1^; *N*-acetyl, *O*-acetyl, or both); and at 432 to 399 cm^−1^.

Except for compounds 15 and 20, all of the above compounds show a band at 1348 to 1316 cm^−1^ (C---H bending); except for compound 12, a band is shown at 1239 to 1211 cm^−1^; and, except for compounds 1, 2, and 14 to 16, a band is shown at 379 to 367 cm^−1^.

The spectra were next examined in groups, as given in [table 2](#t2-jresv65an1p31_a1b){ref-type="table"}.

Bands characteristic of functional groups were found to fall into two categories: (a) Those that maintain their identity, and (b) those that, although present, are obscured or matched by bands (in the same spectral regions) given by compounds not possessing the functional group under consideration. Consequently, bands in the second category have no diagnostic value in the present study.

5.1. Bands That Maintain Their Identity
---------------------------------------

The following bands were shown *only* by compounds (in this study) having the structural features mentioned; possible assignments are given in parentheses. All of the *acetamido* compounds (group 1, [table 2](#t2-jresv65an1p31_a1b){ref-type="table"}) showed at least one band at 3356 to 3236 cm^−1^ (N---H stretching); at 1709 to 1661 cm^−1^ (amide I); and at 1575 to 1541 cm^−1^ (amide IT). Group 1a showed a band at 3268 to 3226 cm^−1^ (or 3257 to 3215 cm^−1^); in the range of 3247 to 3205 cm^−1^, a band is also shown by nine of the other secondary amides (compounds 6 to 10, 12 to 14, and 16), but not by the members of group 5a or by any of the acetylated methyl glycosides previously studied \[[@b3-jresv65an1p31_a1b]\]; hence, the band is presumably attributable to N---H stretching. Group 1a also showed a band at 3125 to 3077 cm^−1^, shown by three other secondary amides (compounds 6, 7, and 13), but not by any of the other compounds just mentioned; thus, this band, too, is probably attributable to N---H stretching.

All of the *acetate esters* (group 2 and the acetylated methyl glycosides) show a band at 1751 to 1736 cm^−1^ (acetate ester, C=O stretching) which is not displayed by the other compounds in this study.

5.2. Bands That, With These Compounds, Are Not Unequivocally Characteristic of Customarily-Assigned Features
------------------------------------------------------------------------------------------------------------

All of the *acetamido* compounds (group 1, [table 2](#t2-jresv65an1p31_a1b){ref-type="table"}) showed bands at 1302 to 1258 cm^−1^ (amide III) and 741 to 699 cm^−1^ (amide V), and at 1124 to 1101 cm^−1^; however, bands in one, two, or all three of these regions are also shown by some *non-nitrogenous* compounds in this study.

All of the *acetate esters* (group 2 and the acetylated methyl glycosides) show a band at 667 to 637 cm^−1^; however, a band in this region is also displayed by compounds 3 to 5 (which are not acetate esters).

For the *primary amides* (group 3), none of the bands customarily regarded as being characteristic of this functional group could be used as an unequivocal indication of its presence. These bands, shown by all the members of group 3, were as follows: At 3356 to 3322 cm^−1^ (bonded NH, N---H stretching) \[shown by three of the secondary amides (compounds 9, 11, and 15)\]; at 3215 to 3205 cm^−1^ (bonded NH, N---H stretching) \[shown by two of the secondary amides (1 and 10)\]; at 1667 to 1661 cm^−1^ (amide I) \[shown by six of the secondary amides (1, 3, 4, 10, 15, 16)\]; at 1445 to 1427 cm^−1^ \[shown by 10 of the secondary amides (1, 2, 5 to 11, and 16), by all but one (compound 22) of the members of group 5a, and by all 24 of the methyl glycoside acetates previously studied \[[@b3-jresv65an1p31_a1b]\]\]; and at 1403 to 1391 cm^−1^ (amide VI) \[shown by three of the secondary amides (4, 5, and 7), by two members of group 5a (17 and 18), and by six methyl glycoside acetates (previous study \[[@b3-jresv65an1p31_a1b]\], compounds 2, 6, 7, 13, 22, and 23)\].

The *hydrates* (group 4) show bands at 1664 to 1642 cm^−1^ that overlap, somewhat obscure, or are obscured by, amide bands in the same region.

As regards the compounds having one or more *hydroxyl groups* (group 5), all of the compounds having an anomeric hydroxyl group only (group 5a) show a band at 3597 to 3367 cm^−1^ (O---H stretching) not displayed by any acetylated methyl glycoside studied \[[@b3-jresv65an1p31_a1b]\]. However, a band in this region is shown by the amides 2, 3, 5, 12, 13, and 15 (having hydroxyl groups) *and* by the amides 8, 11, 14, and, perhaps, 16 (compounds having no hydroxyl group); for these compounds, the band is, presumably, attributable to N---H stretching. Furthermore, as previously mentioned, all of the compounds in the present study (and 19 acetylated methyl aldopyranosides) show a band at 1072 to 1052 cm^−1^ and at 1050 to 1016 cm^−1^, encompassing a region usually associated with vibrations of the O---O---H group.

No bands were noted which could be correlated with the absence (group 6) or presence (group 7) of the pyranoid ring.

The effects, on the spectra, of changing the anomeric group from hydroxyl to (a) acetamido and (b) methoxyl (with all other hydroxyl groups acetylated) are summarized in [table 3](#t3-jresv65an1p31_a1b){ref-type="table"}. For comparison, the bands recorded for tetrahydropyran \[[@b4-jresv65an1p31_a1b]\] are also listed.

Only one anomeric pair of *N*-glycopyranosylacetamides (compounds 10 and 11) was available for intercomparison; bands differentiating between these anomers are listed in [table 4](#t4-jresv65an1p31_a1b){ref-type="table"}.

Barker and coworkers \[[@b5-jresv65an1p31_a1b]\] mentioned that compound 17 (in a Nujol mull) showed bands at 929, 914, 898, 889, 878, and 759 cm^−1^; in this region, our spectrogram 17 (potassium chloride pellet) shows bands at 937, 910, 893, 878, and 768 cm^−1^. The spectra of compounds 18 to 21 in chloroform and in dioxane have been presented previously \[[@b6-jresv65an1p31_a1b]\].

[Figure 1](#f1-jresv65an1p31_a1b){ref-type="fig"} gives the percentage of the *N*-acetylglycosylamines (group 1a) that show absorption bands in the various regions of the infrared spectrum, and [figure 3](#f3-jresv65an1p31_a1b){ref-type="fig"} provides the same kind of information for their acetate esters (group 1b); for convenient comparison, [figure 2](#f2-jresv65an1p31_a1b){ref-type="fig"} shows the positions of bands (cm^−1^) in the infrared absorption spectra of the compounds in groups 1c to 1f. [Figures 4](#f4-jresv65an1p31_a1b){ref-type="fig"} and [5](#f5-jresv65an1p31_a1b){ref-type="fig"} give the percentages of the reducing, pyranose acetates (group 5a) and of the acetylated methyl aldopyranosides of 19 monosaccharides \[[@b3-jresv65an1p31_a1b]\], respectively, that show absorption bands in the various regions of the infrared spectrum. For the range of 5000 to 2000 cm^−1^ in [figures 1](#f1-jresv65an1p31_a1b){ref-type="fig"} to [5](#f5-jresv65an1p31_a1b){ref-type="fig"}, decrements of 20 cm^−1^ in wavenumber were used; and, for the range of 2000 to 250 cm^−1^, decrements of 10 cm^−1^.

6. Experimental Procedures
==========================

6.1. Preparation and Purification of the Compounds
--------------------------------------------------

The compounds listed in [table 1](#t1-jresv65an1p31_a1b){ref-type="table"} were prepared by the methods given in the references cited. The compounds were prepared in the course of earlier studies on the ring structure of *N*-glycosylacetamides, \[[@b7-jresv65an1p31_a1b],[@b8-jresv65an1p31_a1b]\] and reducing, pyranose acetates \[[@b9-jresv65an1p31_a1b]\]. Each compound was recrystallized from an appropriate solvent until further recrystallization caused no change in its melting point or optical rotation.

6.2. Preparation of the Pellets
-------------------------------

Samples for spectrophotometric study were prepared in the solid phase, as pellets consisting of the crystalline compound suspended in an alkali-metal halide, exactly as previously described \[[@b2-jresv65an1p31_a1b]\]. For the range of 5000 to 667 cm^−1^, a concentration of 0.4 mg of compound per 100 mg of potassium chloride was used; a concentration of 2 mg per 100 mg was also used for compound 16. For the range of 667 to 250 cm^−1^, a concentration of 2 mg of compound per 100 mg of potassium iodide was used, except for compound 4 (0.67 mg per 100 mg). Comparisons of intensity of absorption, from one compound to another can only be true and quantitative where the molar concentration is the same.

6.3. Measurement of Infrared Absorption
---------------------------------------

The spectrograms are shown in [figures 6](#f6-jresv65an1p31_a1b){ref-type="fig"} and [7](#f7-jresv65an1p31_a1b){ref-type="fig"}. That in [figure 6](#f6-jresv65an1p31_a1b){ref-type="fig"} for compound 15 was recorded with a Beckman Model IR4 (double beam) spectrophotometer equipped with prisms of sodium chloride. The rest were recorded with a Perkin-Elmer Model 21 (double-beam) spectrophotometer equipped with a prism of sodium chloride (for the range of 5000 to 667 cm^−1^) and of cesium bromide (for the range of 667 to 250 cm^−1^), as previously described \[[@b2-jresv65an1p31_a1b]\].

Some absorption attributable to water (in the compound, the alkali halide, or both) was observed at 3448 and 1639 cm^−1^ and, attributable to atmospheric water vapor, in the far-infrared curves. These regions are drawn on the spectrograms with dashed lines which are not to be interpreted quantitatively.

The authors express their gratitude to Harriet L. Frush for preparing and purifying all of the compounds used in this study, and to J. E. Stewart and J. J. Comeford for recording the infrared absorption spectra.

Figures in brackets indicate the literature references at the end of this paper. The references for [table 1](#t1-jresv65an1p31_a1b){ref-type="table"} are given at the end of the table.
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###### Spectrograms of materials in potassium chloride pellets.

**1**, *N*-Acetyl-*β*-[d]{.smallcaps}-xylopyranosylamine; **2**, *N*-acetyl-*β*-[d]{.smallcaps}-glucopyranosylamine; **3**, *N*-acetyl-*β*-[d]{.smallcaps}-mannopyranosylamine, monohydrate; **4**, *N*-acetyl-*α*-[l]{.smallcaps}-arabinopyranosylamine.

**5**, *N*-acetyl-*β*-[d]{.smallcaps}-galactopyranosylamine; **6**, *N*-acetyl-2,3,4-tri-*O*-acetyl-*β*-[d]{.smallcaps}-xy\]osylamine; **7**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glueosylamine; **8**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-mannosylamine.

**9**, *N*-acetyl-2,3,4-tri-*O*-acetyl-*α*-[l]{.smallcaps}-arabinosylamine; **10**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-galactosylamine; **11**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactosylamine; **12**, -acetamido-1-deoxy-?-[d]{.smallcaps}-mannopyranuronamide.

**13**, 1-acetamido-1-deoxy-?-[d]{.smallcaps}-galactopyranuronamide, pentahydrate; **14**, 1-acetamido-2,3,4-tri-*O*-acetyl-1-deoxy-?-[d]{.smallcaps}-mannuronamide; **15**, 1,1-bis(acetamido)-1-deoxy [l]{.smallcaps}-arabinitol; **16**, 1,1-bis(acetamido)-2,3,4,5-tetra-*O*-acetyl-1-deoxy-[l]{.smallcaps}-arabinitol.

**17**, 2,3,4-tri-O-acetyl-*α*-[d]{.smallcaps}-xylopyranose; **18**, 1,2,3,4-tetra-*O*-acetyl-*α*-[l]{.smallcaps}-*xylo*-hexulopyranose; **19**, 2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucopyranose; **20**, 1,3,4,5,7-penta-*O*-acetyl-*α*-[d]{.smallcaps}-*gluco*-heptulopyranose.

**21**, 2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-mannopyranose; **22**, 1,3,4,5-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-*arabino*-hexulopyranose; **23**, 2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactopyranose; **24**, 2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-talopyranose.
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###### Spectrograms of materials in potassium iodide pellets.

**1**, *N*-Acety-*β*-[d]{.smallcaps}-xylopyranosylainine; **2**, *N*-acetyl-*β*-[d]{.smallcaps}-glucopyranosylamine; **3**, *N*-acetyl-*β*-[d]{.smallcaps}-mannopyranosylamine, monohydrate; **4**, *N*-acetyl-a-[l]{.smallcaps}-arabinopyranosylamine.

**5**, *N*-acetyl-*β*-[d]{.smallcaps}-galactopyranosylamine; **6**, *N*-acetyl-2,3,4,tri-*O*-acetyl-*β*-[d]{.smallcaps}-xylosylamine; **7**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucosylamine; **8**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-mannosylamine.

**9**, *N*-acetyl-2,3,4-tri-*O*-acetyl-*α*-[l]{.smallcaps}-arabinosylamine; **10**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-galactosylamine; **11**, *N*-acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactosylamine; **12**, 1-acetamido-1-deoxy-?-[d]{.smallcaps}-mannopyranuronamide.

**13**, 1-acetamido-1-deoxy-?-[d]{.smallcaps}-galactopyranuronamide, pentahydrate; **14**, 1-acetaraido-2,3,4-tri-*O*-acetyl-1-deoxy-?-[d]{.smallcaps}-mannuronamide; **15**, 1,1-bis(acetamido)-1-deoxy-[l]{.smallcaps}-arabinitol; **16**, 1,1-bis(acetamido)-2,3,4,5-tetra-*O*-acetyl-1-deoxy-[l]{.smallcaps}-arabinitol.

**17**, 2,3,4-tri-*O*-acetyl-*α*-[d]{.smallcaps}-xylopyranose; **18**, 1,3,4,5-tetra-*O*-acetyl-*α*-[l]{.smallcaps}-*xylo*-hexulopyranose; **19**, 2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucopyranose; **20**, 1,3,4,5,7-penta-*O*-acetyl-*α*-[d]{.smallcaps}-*gluco*-heptulopyranose.

**21**, 2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-mannopyranose; **22**, 1,3,4,5-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-*arabino*-hexulopyranose; **23**, 2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactopyranose; **24**, 2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-talopyranose.
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###### 

Compounds measured and index to spectrograms

  Code                                          Compound                                                                          Reference                                               Spectrogram
  --------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------- -------------
                                                                                                                                                                                          
  A. *N*-GLYCOPYRANOSYLACETAMIDES                                                                                                                                                         
                                                                                                                                                                                          
                                                1\. *Unsubstituted*                                                                                                                       
  10.11?82                                      *N*-Acetyl-*β*-[d]{.smallcaps}-xylopyranosylamine                                 [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       1
  10.21?82                                      *N*-Acetyl-*β*-[d]{.smallcaps}-glucopyranosylamine                                [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       2
  10.22?8299                                    *N*-Acetyl-*β*-[d]{.smallcaps}-mannopyranosylamine, monohydrate.                  [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       3
  10.13?82                                      *N*-Acetyl-*α*-[l]{.smallcaps}-arabinopyranosylamine                              [2](#tfn3-jresv65an1p31_a1b){ref-type="table-fn"}       4
  10.23?82                                      *N*-Acetyl-*β*-[d]{.smallcaps}-galactopyranosylamine                              [3](#tfn4-jresv65an1p31_a1b){ref-type="table-fn"}       5
                                                2\. *Acetate esters*                                                                                                                      
  12.11?82                                      *N*-Acetyl-2,3,4-tri-*O*-acetyl-*β*-[d]{.smallcaps}-xylosylamine                  [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       6
  12.21?82                                      *N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucosylamine.            [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       7
  12.22?82                                      *N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-mannosyl amine.           [1](#tfn2-jresv65an1p31_a1b){ref-type="table-fn"}       8
  12.13?82                                      *N*-Acetyl-2,3,4-tri-*O*-acetyl-*α*-[l]{.smallcaps}-arabinosylamine               [2](#tfn3-jresv65an1p31_a1b){ref-type="table-fn"}       9
  12.23?82                                      *N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*α*-[d]{.smallcaps}-galactosylamine.          [3](#tfn4-jresv65an1p31_a1b){ref-type="table-fn"}       10
  12.23?82                                      *N*-Acetyl-2,3,4,6-tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactosylamine.          [3](#tfn4-jresv65an1p31_a1b){ref-type="table-fn"}       11
                                                                                                                                                                                          
  B. *N*-(GLYCOPYRANOSYLURONAMIDE) ACETAMIDES                                                                                                                                             
                                                                                                                                                                                          
  10.22?8274                                    1-Aectamido-1-deoxy-?-[d]{.smallcaps}-mannopyranuronamide                         [4](#tfn5-jresv65an1p31_a1b){ref-type="table-fn"}       12
  10.23?827499                                  1-Acetamido-1-deoxy-?-[d]{.smallcaps}-galactopyranuronamide pentahydrate.         [5](#tfn6-jresv65an1p31_a1b){ref-type="table-fn"}       13
  12.22?8274                                    1-Acetamido-2,3,4-tri-*O*-acetyl-1-deoxy-?-[d]{.smallcaps}-mannuronamide.         [4](#tfn5-jresv65an1p31_a1b){ref-type="table-fn"}       14
                                                                                                                                                                                          
  C. 1,1-BIS(ACETAMIDO)-1-DEOXYALDITOLS                                                                                                                                                   
                                                                                                                                                                                          
  10.13782                                      1,1-Bis(acetamido)-1-deoxy-[l]{.smallcaps}-arabinitol                             [6](#tfn7-jresv65an1p31_a1b){ref-type="table-fn"}       15
  12.1375282                                    1,1-Bis(acetamido)-2,3,4,5-tetra-*O*-acetyl-1-deoxy-[l]{.smallcaps}-arabinitol.     ([a](#tfn1-jresv65an1p31_a1b){ref-type="table-fn"})   16
                                                                                                                                                                                          
  D. REDUCING, PYRANOSE ACETATES                                                                                                                                                          
                                                                                                                                                                                          
  12.11?0                                       2,3,4-Tri-*O*-acetyl-*α*-[d]{.smallcaps}-xylopyranose                             [7](#tfn8-jresv65an1p31_a1b){ref-type="table-fn"}       17
  12.71?0                                       1,3 4,5-Tetra-*O*-acetyl-*α*-[l]{.smallcaps}-*xylo*-hexulopyranose                [8](#tfn9-jresv65an1p31_a1b){ref-type="table-fn"}       18
  12.21?0                                       2,3,4,6-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-glucopyranose                        [9](#tfn10-jresv65an1p31_a1b){ref-type="table-fn"}      19
  12.81?0                                       1,3,4,5,7-Penta-*O*-acetyl-*α*-[d]{.smallcaps}-*gluco*-heptulopyranose.           [10](#tfn11-jresv65an1p31_a1b){ref-type="table-fn"}     20
  12.22?0                                       2,3,4,6-Tetra-*O*-acetyl-*α*-[d]{.smallcaps}-mannopyranose                        [11](#tfn12-jresv65an1p31_a1b){ref-type="table-fn"}     21
  12.73?0                                       1,3,4,5-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-*arabino*-hexulopyranose.            [12](#tfn13-jresv65an1p31_a1b){ref-type="table-fn"}     22
  12.23?0                                       2,3,4,6-Tetra-*O*-acetyl-*β*-[d]{.smallcaps}-galactopyranose                      [13](#tfn14-jresv65an1p31_a1b){ref-type="table-fn"}     23
  12.24?0                                       2,3,4,6-Tetra-*O*-acetyl-*α*-[d]{.smallcaps}-talopyranose                         [14](#tfn15-jresv65an1p31_a1b){ref-type="table-fn"}     24
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###### 

Structural groups studied

  Group   Structural feature                       Compounds (serial numbers) in group
  ------- ---------------------------------------- -------------------------------------
                                                   
  1       Acetamido (amide, secondary)             1 to 16
  1a      *N*-Acetyl                               1 to 5
  1b      *N*-Acetyl-*O*-acetyl                    6 to 11
  1c      *N*-Acetyl; amide (primary)              12, 13
  1d      *N*-Acetyl-*O*-acetyl; amide (primary)   14
  1e      *N*-Acetyl; open chain                   15
  1f      *N*-Acetyl-*O*-acetyl; open chain        16
  2       *O*-Acetyl                               6 to 11, 14, 16, 17 to 24
  3       Amide, primary                           12 to 14
  4       Hydrate                                  3, 13
  5       Hydroxyl group                           1 to 5, 12, 13, 15, 17 to 24
  5a      Anomeric hydroxyl group, only            17 to 24
  6       Open chain                               15, 16
  7       Pyranoid ring                            1 to 14, 17 to 24

###### 

Effect of changing the anomeric group from hydroxyl to (a) acetamido and (b) methoxyl; and comparison with hands of tetrahydropyran

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bands (cm^−1^) of tetrahydropyran[a](#tfn16-jresv65an1p31_a1b){ref-type="table-fn"}   Spectral range of bands (cm^−1^) shown by every member of the group of compounds                                           
  ------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- --------------------------------------- -----------------------------------------
                                                                                                                                                                                                                   

  .................................                                                     3597 to 3367                                                                       .................................       .................................

  .................................                                                     .................................                                                  3378 to 3268                            .................................

  .................................                                                     .................................                                                  or 3356 to 3236                         .................................

  .................................                                                     2994 to 2976                                                                       2994 to 2950                            2994 to 2950

  .................................                                                     2959 to 2907                                                                       or 2976 to 2907                         $\left\{ \begin{matrix}
                                                                                                                                                                                                                   {\text{or}\ 2985\ \text{to}\ 2941\ } \\
                                                                                                                                                                                                                   {\text{or}\ 2976\ \text{to}\ 2907} \\
                                                                                                                                                                                                                   \end{matrix} \right.$

  .................................                                                     .................................                                                  .................................       or 2915 to 2841

  .................................                                                     .................................                                                  .................................       .................................

  .................................                                                     1757 to 1742                                                                       $\}\begin{matrix}                       1751 to 1736
                                                                                                                                                                           {\ 1751\ \text{to}\ 1742\ } \\          
                                                                                                                                                                           {\text{or}\ 1742\ \text{to}\ 1727} \\   
                                                                                                                                                                           \end{matrix}$                           

  .................................                                                     or 1751 to 1736                                                                    .................................       

  .................................                                                     or 1742 to 1718                                                                    .................................       

  .................................                                                     .................................                                                  1701 to 1675                            .................................

  .................................                                                     .................................                                                  1565 to 1555                            .................................

  .................................                                                     .................................                                                  or 1560 to 1536                         .................................

  .................................                                                     1477 to 1462                                                                       .................................       1473 to 1456

  .................................                                                     .................................                                                  .................................       or 1462 to 1447

  1451                                                                                  1449 to 1433                                                                       1441 to 1433                            1443 to 1433

  1381                                                                                  1385 to 1374                                                                       .................................       1385 to 1372

  .................................                                                     or 1377 to 1372                                                                    1374 to 1368                            or 1379 to 1368

  1348                                                                                  [b](#tfn17-jresv65an1p31_a1b){ref-type="table-fn"}1340 to 1323                     $\left\{ {\ \begin{matrix}              1348 to 1321
                                                                                                                                                                           {1333\ \text{to}\ 1316} \\              
                                                                                                                                                                           {\text{or}\ 1325\ \text{to}\ 1312} \\   
                                                                                                                                                                           \end{matrix}} \right.\ $                

  or 1335 to 1318                                                                                                                                                                                                  

  1296                                                                                  .................................                                                  1299 to 1258                            .................................

  1272                                                                                  1271 to 1247                                                                       or 1279 to 1253                         1264 to 1247

  1256                                                                                  .................................                                                  or 1253 to 1238                         or 1256 to 1239

  .................................                                                     .................................                                                  or 1241 to 1229                         .................................

  .................................                                                     1230 to 1221                                                                       or 1238 to 1224                         1236 to 1221

  .................................                                                     .................................                                                  or 1229 to 1217                         or 1227 to 1217

  1202                                                                                  .................................                                                  or 1224 to 1211                         or 1224 to 1202

  .................................                                                     .................................                                                  .................................       1200 to 1172

  .................................                                                     .................................                                                  1179 to 1166                            or 1190 to 1167

  1160                                                                                  1166 to 1152                                                                       or 1168 to 1149                         .................................

  .................................                                                     1140 to 1127                                                                       or 1126 to 1114                         1148 to 1115

  .................................                                                     .................................                                                  (or 1122 to 1106)                       .................................

  .................................                                                     .................................                                                                                          1114 to 1086

  1097                                                                                  1105 to 1076                                                                       } or 1107 to 1074                       

  .................................                                                     1070 to 1054                                                                       $\left\{ {\ \begin{matrix}              1068 to 1052\
                                                                                                                                                                           {\text{or}\ 1070\ \text{to}\ 1056} \\   or 1060 to 1042
                                                                                                                                                                           {\text{or}\ 1068\ \text{to}\ 1049} \\   
                                                                                                                                                                           \end{matrix}} \right.$                  

  1050                                                                                  1050 to 1041                                                                       or 1059 to 1041                         } or 1026 to 1022

  1033                                                                                  .................................                                                  or 1041 to 1016                         

  .................................                                                     .................................                                                  or 1021 to 1005                         or 1026 to 1006

  1012                                                                                  .................................                                                  (or 1016 to 1003)                       .................................

  .................................                                                     .................................                                                  or 1014 to 996                          } 1006 to 977

  .................................                                                     .................................                                                  or 996 to 979                           

  .................................                                                     989 to 978                                                                         or 989 to 972                           } or 984 to 951

  969                                                                                   .................................                                                  967 to 955                              

  .................................                                                     .................................                                                  or 965 to 948                           .................................

  .................................                                                     962 to 938                                                                         or 958 to 947                           } or 958 to 933

  .................................                                                     or 952 to 921                                                                      940 to 914                              

  .................................                                                     911 to 898                                                                         909 to 904                              917 to 903

  .................................                                                     (or 910 to 896)                                                                    (or 907 to 902)                         .................................

  .................................                                                     or 907 to 893                                                                      .................................       or 907 to 897

  .................................                                                     (or 905 to 891)                                                                    .................................       .................................

  .................................                                                     .................................                                                  .................................       898 to 875

  875,856,818                                                                           887 to 864                                                                         880 to 862                              or 889 to 867

  .................................                                                     .................................                                                  741 to 711                              .................................

  .................................                                                     .................................                                                  678 to 665                              .................................

  .................................                                                     676 to 656                                                                         or 673 to 648                           666 to 648

  .................................                                                     .................................                                                  (or 665 to 645)                         .................................

  .................................                                                     656 to 642                                                                         or 655 to 637                           or 660 to 638

  .................................                                                     .................................                                                  or 649 to 635                           or 649 to 626

  .................................                                                     636 to 615                                                                         .................................       or 638 to 619

  .................................                                                     .................................                                                  615 to 600                              or 622 to 603

  .................................                                                     .................................                                                  (or 608 to 599)                         .................................

  .................................                                                     604 to 597                                                                         or 605 to 597                           or 612 to 597

  .................................                                                     .................................                                                  or 600 to 587                           or 602 to 577

  .................................                                                     .................................                                                  or 591 to 579                           or 596 to 571

  .................................                                                     .................................                                                  or 581 to 561                           .................................

  .................................                                                     .................................                                                  (or 579 to 558)                         .................................

  .................................                                                     571 to 544                                                                         or 570 to 546                           .................................

  .................................                                                     or 562 to 522                                                                      546 to 522                              .................................

  .................................                                                     525 to 516                                                                         $\left\{ {\ \begin{matrix}              .................................
                                                                                                                                                                           {\text{or}\ 533\ \text{to}\ 516} \\     
                                                                                                                                                                           {(\text{or}\ 529\ \text{to}\ 515)} \\   
                                                                                                                                                                           \end{matrix}} \right.\ $                

  .................................                                                     .................................                                                  509 to 493                              } 520 to 491

  .................................                                                     .................................                                                  .................................       or 499 to 482

  .................................                                                     489 to 476                                                                         .................................       or 491 to 475

  .................................                                                     .................................                                                  .................................       470 to 451

  .................................                                                     455 to 442                                                                         .................................       .................................

  .................................                                                     .................................                                                  420 to 409                              }  428 to 399

  .................................                                                     419 to 402                                                                         $\left\{ {\ \begin{matrix}              
                                                                                                                                                                           {(\text{or}\ 417\ \text{to}\ 408)} \\   
                                                                                                                                                                           {\text{or}\ 414\ \text{to}\ 400} \\     
                                                                                                                                                                           \end{matrix}} \right.$                  

  .................................                                                     or 403 to 390                                                                      (or 412 to 398)                         .................................

  .................................                                                     or 398 to 384                                                                      or 398 to 383                           .................................

  .................................                                                     379 to 374                                                                         379 to 375                              376 to 367

  .................................                                                     296 to 279                                                                         .................................       .................................
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Bands recorded by Burket and Badger \[[@b4-jresv65an1p31_a1b]\].

Except compound 20.

###### 

Bands (cm^−1^) differentiating between the anomers of *N*-acetyl-2,8,4,6-tetra-*O*-acetyl-*[d]{.smallcaps}*-galactosylamine

  10 (*α*)    11 (*β*)    10 (*α*)    11 (*β*)
  ----------- ----------- ----------- ----------
                                      
  3215        .........   .........   1408
  3058        .........   .........   1376
  2801        .........   .........   1333
  1664        .........   .........   1253
  1106        .........   .........   1037
  1064        .........   .........   870
  943         .........   .........   667
  834         .........   .........   533
  711         .........   .........   493
  307         .........   .........   452
  .........   2941        .........   445
  .........   2890        .........   430
  .........   1751        .........   361
  .........   1513        .........   355
  .........   1473        .........   348
  .........               .........   341
